COVID-19
coronavirus disease 2019 (COVID-19) is an infectious respiratory disease caused by severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), a betacoronavirus first identified in late 2019 that spread globally as a pandemic.
coronavirus disease 2019 (COVID-19) is an infectious respiratory disease caused by severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), a betacoronavirus first identified in late 2019 that spread globally as a pandemic. Transmission occurs predominantly through respiratory aerosols and droplets, including airborne spread in poorly ventilated indoor settings. The virus enters host cells by binding its spike receptor-binding domain to angiotensin-converting enzyme 2 (ACE2), after which host proteases — furin during particle assembly and TMPRSS2 or endosomal cathepsins at entry — cleave the spike to release the fusion machinery; inside, the viral main protease (Mpro) and other nonstructural proteins process the polyproteins that build the replication complex. Because the receptor-binding domain is also the dominant antibody target, successive variants have accumulated substitutions there, which is why immune escape and vaccine reformulation have driven the epidemiology since 2021.
Clinical presentation ranges from asymptomatic infection through mild upper respiratory illness to pneumonia, acute respiratory distress syndrome, coagulopathy and multi-organ failure. Severe disease reflects dysregulated innate and adaptive activation involving interferons such as interferon gamma (Ifng), Interleukin-6 (IL-6) and other inflammatory mediators, with C-reactive protein and detectable circulating viral RNA used as severity markers — and the timing of that shift matters therapeutically, since the early phase is driven by replication and the later by the host response. A subset of patients develops persistent post-acute sequelae, or Long COVID, in which fatigue, cognitive complaints, chronic cough and airway hyperresponsiveness continue after viral clearance.
Treatment follows that division. Antivirals are given early: direct-acting inhibitors of the main protease, exemplified by nirmatrelvir with the pharmacokinetic booster ritonavir, and monoclonal or single-domain (VHH) antibodies against the spike receptor-binding domain, whose usefulness has repeatedly lapsed as variants escape them. Host-directed agents such as inhibitors of dihydroorotate dehydrogenase (DHODH), the rate-limiting enzyme of de novo pyrimidine synthesis, target a cellular dependency instead and so impose a higher barrier to viral escape. For patients already deteriorating on oxygen, benefit comes from damping the response rather than the virus — dexamethasone reduced mortality in that group, and interleukin-6 receptor blockade with tocilizumab adds to it. Prophylaxis rests chiefly on mRNA-based COVID-19 vaccines, which elicit spike-specific antibodies alongside CD4+ and CD8+ T-lymphocyte responses; protection is attenuated in immunocompromised groups, including transplant recipients, patients with hematologic malignancy or CD19-directed chimeric antigen receptor T cell therapy, people with chronic renal insufficiency, older adults, and individuals with conditions such as Down syndrome that carry intrinsic immune dysregulation. Beyond acute illness, the pandemic strained health systems worldwide, disrupted cancer, surgical, antiretroviral and mental health services, accelerated telemedicine, and reshaped vaccine technology and trial methodology.
Where the papers sit
24 papers from the last 6 months study COVID-19 directly · updated from PubMed 16 Nov 2026
Study type 1 clinical trial · 11 observational · 7 human data · 2 preclinical · 3 unclassified
Themes one subject
Those 24 are all about one subject.
-
Vaccination and Population Health
Vaccination policy is being evaluated beyond uptake, linking coverage and willingness with effectiveness, safety, equity and broader health outcomes. Recurring concerns include missed preventive care, social and ethnic inequalities, disability, deprivation, and access to routine and combination influenza/COVID-19 vaccination. Registry and cohort analyses examine protection against hospitalization and infection while monitoring uncommon events such as stroke and corneal graft rejection. Longer-term associations with quality of life, cancer and brain atrophy remain observational or genetically supported rather than definitive, leaving causality and equitable delivery open.
Papers
The 24 papers from the last 6 months that study COVID-19 directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Vaccination and Population Health (24)
- Pharmacists' perspectives on efficiencies and other benefits of combination influenza/COVID-19 vaccination. Journal of medical economics · 9 Nov 2026 PMID 43001902
- An investigation into post-pandemic ethnic group and deprivation inequalities in influenza and COVID-19 hospitalizations. Epidemiology and infection · 26 Oct 2026 PMID 42929057
- COVID-19 among people with intellectual disability in comparison to the general population: diagnoses, hospitalizations, deaths, and vaccinations (IDcare). BMC public health · 16 Oct 2026 PMID 42881375
- Postpandemic COVID-19 Vaccination Willingness Among Physicians and Medical Trainees in China: Cross-Sectional Study. JMIR public health and surveillance · 6 Oct 2026 PMID 42837522
- Adult vaccination coverage and missed preventive care opportunities among Filipino adults with diabetes: A cross-sectional study. Human vaccines & immunotherapeutics · 2 Oct 2026 PMID 42826175
- Summary of National Surveillance Data on Vaccine Preventable Diseases in Australia, 2019-2022. Communicable diseases intelligence (2018) · 28 Sept 2026 PMID 42805160
- Associations of age, COVID-19 vaccination, and SARS-CoV-2 infection history with health-related quality of life in a community-based longitudinal cohort in Singapore. Journal of infection and public health · 16 Sept 2026 PMID 42748761
- Are both COVID-19 and COVID-19 vaccines associated with cancer? Oncotarget · 11 Sept 2026 PMID 42725534
- Increased risk of corneal transplant rejection following SARS-CoV-2 infection and vaccination. International ophthalmology · 9 Sept 2026 PMID 42714722
- Pull-forward and induced vaccination under time-limited mandates: Evidence from a low-coercion mandate. Social science & medicine (1982) · 7 Sept 2026 PMID 42704982
- How the unvaccinated have been portrayed in the urban English-language Canadian popular press since the declared end of the COVID-19 pandemic emergency. Human vaccines & immunotherapeutics · 25 Aug 2026 PMID 42638279
- Cohort studies may underestimate rare vaccine adverse events: evidence from stroke incidence following COVID-19 vaccination. Expert review of vaccines · 24 Aug 2026 PMID 42635361
- 2024-2025 BNT162b2 KP.2 COVID-19 full season vaccine effectiveness from vaccine registries linked to administrative claims in two states: A cohort study in non-immunocompromised adults. Vaccine · 13 Aug 2026 PMID 42594639
- The association of individual, interpersonal and social support factors with willingness to vaccinate against COVID-19 in rural South Africa. Vaccine · 5 Aug 2026 PMID 42556300
- Suboptimal vaccine coverage for preventable respiratory infections in children with cystic fibrosis in the Cystic Fibrosis Regional Reference Centre of Tuscany: Need for improving preventive strategies. Human vaccines & immunotherapeutics · 29 Jun 2026 PMID 42373575
- Genetic evidence that advanced COVID-19 accelerates longitudinal brain atrophy: A Mendelian randomization study. Medicine · 27 Jun 2026 PMID 42363551
- Oligo(ethylene glycol)-functionalized polycarbonate lipid nanoparticles for mRNA delivery with attenuated PEG immunogenicity. Journal of controlled release : official journal of the Controlled Release Society · 26 Jun 2026 PMID 42361911
- Association of SARS-CoV-2 infection with incident diabetes among U.S. Veterans in a prospective longitudinal cohort. PloS one · 26 Jun 2026 PMID 42361118
- Serological Profiling and Neuro-Immune Resilience: The Dissociation Between Anti-SARS-CoV-2 Antibodies and Post-Viral Airway Hyperresponsiveness in Pediatric Asthma. Lung · 23 Jun 2026 PMID 42337098
- DHODH Inhibitors Based on the Vidofludimus Scaffold Containing Carboxylic Acid Bioisosteres Exert a Superior Broad-Spectrum Antiviral Activity. Journal of medicinal chemistry · 3 Jun 2026 PMID 42233404
- T-cell responses to primary SARS-CoV-2 vaccination in Down syndrome - From childhood to adulthood. Human vaccines & immunotherapeutics · 1 Jun 2026 PMID 42223472
- Self-reported vaccine uptake across six infectious diseases among gay, bisexual, transgender, and non-binary individuals in Australia: findings from a 2024 national survey. Sexual health · 31 May 2026 PMID 42219251
- Characterization of the VHH-Fc construct rimteravimab in healthy adults and patients hospitalized for mild-to-moderate COVID-19: Two Phase 1 randomized clinical trials. PLoS medicine · 29 May 2026 PMID 42213671
- Design, Synthesis, and Evaluation of Novel Thiazole-Based Peptidomimetic Compounds as Potent SARS-CoV-2 Main Protease Covalent Inhibitors. ACS infectious diseases · 20 May 2026 PMID 42160697
By study type
Clinical trials (1)
- Characterization of the VHH-Fc construct rimteravimab in healthy adults and patients hospitalized for mild-to-moderate COVID-19: Two Phase 1 randomized clinical trials. PLoS medicine · 29 May 2026 PMID 42213671
Observational studies and case reports (11)
- Pharmacists' perspectives on efficiencies and other benefits of combination influenza/COVID-19 vaccination. Journal of medical economics · 9 Nov 2026 PMID 43001902
- COVID-19 among people with intellectual disability in comparison to the general population: diagnoses, hospitalizations, deaths, and vaccinations (IDcare). BMC public health · 16 Oct 2026 PMID 42881375
- Postpandemic COVID-19 Vaccination Willingness Among Physicians and Medical Trainees in China: Cross-Sectional Study. JMIR public health and surveillance · 6 Oct 2026 PMID 42837522
- Adult vaccination coverage and missed preventive care opportunities among Filipino adults with diabetes: A cross-sectional study. Human vaccines & immunotherapeutics · 2 Oct 2026 PMID 42826175
- Associations of age, COVID-19 vaccination, and SARS-CoV-2 infection history with health-related quality of life in a community-based longitudinal cohort in Singapore. Journal of infection and public health · 16 Sept 2026 PMID 42748761
- Increased risk of corneal transplant rejection following SARS-CoV-2 infection and vaccination. International ophthalmology · 9 Sept 2026 PMID 42714722
- Cohort studies may underestimate rare vaccine adverse events: evidence from stroke incidence following COVID-19 vaccination. Expert review of vaccines · 24 Aug 2026 PMID 42635361
- Suboptimal vaccine coverage for preventable respiratory infections in children with cystic fibrosis in the Cystic Fibrosis Regional Reference Centre of Tuscany: Need for improving preventive strategies. Human vaccines & immunotherapeutics · 29 Jun 2026 PMID 42373575
- Association of SARS-CoV-2 infection with incident diabetes among U.S. Veterans in a prospective longitudinal cohort. PloS one · 26 Jun 2026 PMID 42361118
- Serological Profiling and Neuro-Immune Resilience: The Dissociation Between Anti-SARS-CoV-2 Antibodies and Post-Viral Airway Hyperresponsiveness in Pediatric Asthma. Lung · 23 Jun 2026 PMID 42337098
- T-cell responses to primary SARS-CoV-2 vaccination in Down syndrome - From childhood to adulthood. Human vaccines & immunotherapeutics · 1 Jun 2026 PMID 42223472
Human data, design not indexed (7)
- An investigation into post-pandemic ethnic group and deprivation inequalities in influenza and COVID-19 hospitalizations. Epidemiology and infection · 26 Oct 2026 PMID 42929057
- Summary of National Surveillance Data on Vaccine Preventable Diseases in Australia, 2019-2022. Communicable diseases intelligence (2018) · 28 Sept 2026 PMID 42805160
- Are both COVID-19 and COVID-19 vaccines associated with cancer? Oncotarget · 11 Sept 2026 PMID 42725534
- Pull-forward and induced vaccination under time-limited mandates: Evidence from a low-coercion mandate. Social science & medicine (1982) · 7 Sept 2026 PMID 42704982
- How the unvaccinated have been portrayed in the urban English-language Canadian popular press since the declared end of the COVID-19 pandemic emergency. Human vaccines & immunotherapeutics · 25 Aug 2026 PMID 42638279
- The association of individual, interpersonal and social support factors with willingness to vaccinate against COVID-19 in rural South Africa. Vaccine · 5 Aug 2026 PMID 42556300
- Self-reported vaccine uptake across six infectious diseases among gay, bisexual, transgender, and non-binary individuals in Australia: findings from a 2024 national survey. Sexual health · 31 May 2026 PMID 42219251
Preclinical: animal, cell and lab studies (2)
- DHODH Inhibitors Based on the Vidofludimus Scaffold Containing Carboxylic Acid Bioisosteres Exert a Superior Broad-Spectrum Antiviral Activity. Journal of medicinal chemistry · 3 Jun 2026 PMID 42233404
- Design, Synthesis, and Evaluation of Novel Thiazole-Based Peptidomimetic Compounds as Potent SARS-CoV-2 Main Protease Covalent Inhibitors. ACS infectious diseases · 20 May 2026 PMID 42160697
Unclassified: not yet indexed with MeSH (3)
- 2024-2025 BNT162b2 KP.2 COVID-19 full season vaccine effectiveness from vaccine registries linked to administrative claims in two states: A cohort study in non-immunocompromised adults. Vaccine · 13 Aug 2026 PMID 42594639
- Genetic evidence that advanced COVID-19 accelerates longitudinal brain atrophy: A Mendelian randomization study. Medicine · 27 Jun 2026 PMID 42363551
- Oligo(ethylene glycol)-functionalized polycarbonate lipid nanoparticles for mRNA delivery with attenuated PEG immunogenicity. Journal of controlled release : official journal of the Controlled Release Society · 26 Jun 2026 PMID 42361911
Written from 24 PubMed abstracts, each one listed by PMID above. Published: 2026-06-13. Last written: 2026-09-13 by GPT. Corrections: 2026-08-08 by GPT. Reviewed by a human editor on 2026-07-23. Drafted by language models from published abstracts; not medical advice.